Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 21, 2012; 18(47): 6967-6973
Published online Dec 21, 2012. doi: 10.3748/wjg.v18.i47.6967
Published online Dec 21, 2012. doi: 10.3748/wjg.v18.i47.6967
Figure 1 Relative percentages of male and female patients experiencing adverse drug reactions to “classical” immune suppressive agents (thiopurines, methotrexate, cyclosporine and tacrolimus) and anti-tumor necrosis factor agents.
A: Adverse drug reactions (ADR) to immune suppressive agents in general; B: ADR to respective immunosuppressive agents; C: ADR to anti-tumor necrosis factor agents (anti-TNF) in general; D: ADR to respective anti-TNF agents. 1Two-sided χ2 test. Black bars: ADR present; Gray bars: No ADR.
- Citation: Zelinkova Z, Bultman E, Vogelaar L, Bouziane C, Kuipers EJ, van der Woude CJ. Sex-dimorphic adverse drug reactions to immune suppressive agents in inflammatory bowel disease. World J Gastroenterol 2012; 18(47): 6967-6973
- URL: https://www.wjgnet.com/1007-9327/full/v18/i47/6967.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i47.6967